Senior Vice President R&D, Regulatory and Scientific Affairs Bruker DALTONICS Microbiology & Diagnostics
BIOGRAPHY
Speaker
Event Date & Time
Date: October 13, 2020
Time: 5:00am (PDT), 8:00am (EDT), 2:00 pm (CEST)
Abstract
Dr. Markus Kostrzewa shall elaborate the progress that has been made in Bruker Microbiology & Diagnostics (M&D) Research and Development, including new product launches as well as improvements of existing systems. Also, provisional results of some ongoing innovation projects and studies will be reported. The topics will cover the whole area of Bruker M&D R&D, including MALDI Biotyper®, IR Biotyper®, susceptibility testing and PCR technology.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 24, 2023 | 10:00 AM
Dynamic changes in chromatin drive gene expression programs during cellular development and contribute to pathological changes underlying disease. To date, efforts to characterize chromatin...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
FEB 08, 2024 | 10:00 AM
High-content screening (HCS) is an imaging-based, multi-parametric strategy used in drug development that generates rich datasets through multiplexing strategically chosen fluorescent dyes a...
Loading Comments...
Finish Registering
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024 -
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
JUN 06, 2024The Future of Scientific Conferencing
- See More
-
APR 19, 2024
-
APR 19, 2024
- See More
